Posted on August 19, 2021 by Sitemaster
A new paper by Meissner et al. has reported important, long-term data on fear of recurrence and biochemical progression of prostate cancer among a large cohort of German patients undergoing radical prostatectomy. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: fear, outcome, recurrence, surgery, survey | 3 Comments »
Posted on June 26, 2020 by Sitemaster
The American Urological Association (AUA), together with the American Society for Radiation Oncology (ASTRO) and the Society for Urologic Oncology (SUO), has just issued a new set of guidelines for the management of advanced prostate cancer (see here). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: advanced, biochemical, castration-resistant, guideline, hormone-sensitive, metastatic, recurrence | 8 Comments »
Posted on April 30, 2020 by Sitemaster
A new report from a relatively small, single-institution study has provided additional information about the utility of [18F]fluciclovine (Axumin) PET/CT scans in the detection of recurrent prostate cancer after definitive first-line treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Axumin, fluciclovine, PET/CT, recurrence, scan | 2 Comments »
Posted on August 19, 2019 by Sitemaster
There is no standard definition of SECOND biochemical (PSA-detected) recurrence (BCR); that is, recurrence after both prostatectomy and salvage radiation (SRT). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: BCR, biochemical, definition, fourth, recurrence, second, third | 2 Comments »
Posted on April 24, 2019 by Sitemaster
A media release issued yesterday by Progenics Pharmaceuticals states that the investigational imaging agent 18F-DCFPyL changed physician behavior in the management of biochemically recurrent prostate cancer in > 65 percent of patients. … READ MORE …
Filed under: Uncategorized | Tagged: 18F-DCFPyL, biochemical, change, CT, imaging, Management, PET, recurrence, scan | Leave a comment »
Posted on January 30, 2019 by Sitemaster
The results of a small, randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients already treated on intermittent androgen deprivation therapy (IADT) have recently been published. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adbrogen, curcumin, deprivation, duration, IADT, intermittent, recurrence, tim | 8 Comments »
Posted on October 24, 2018 by Sitemaster
We didn’t expect to see data from the SPPORT trial for another 2 years, but the research team hit their recruitment goal early and have already been able to provide 5-year results. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical, clinical, post-prostatectomy, radiation, recurrence, salvage, SPPORT | 14 Comments »
Posted on October 16, 2018 by Sitemaster
Back in January this year we commented on a technique known as Retzius-sparing radical prostatectomy, which — according to its advocates — is said to facilitate recovery of erectile function post-surgery. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biochemical, outcome, recurrence, Retzius-sparing, risk, surgery | Leave a comment »
Posted on October 24, 2017 by Sitemaster
A company based on Northern Ireland called Almac Diagnostics has been working on the development of a 70-gene genetic assay (which they refer to as their Prostate Cancer Metastatic Assay) capable of projecting probability of metastasis-free survival in men treated for prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: metastasis, prognosis, recurrence | 6 Comments »
Posted on September 28, 2017 by Sitemaster
The value of many cancer-related tests is actually based on whether the results of the particular test change the way that physicians plan to treat specific patients (hopefully for the better). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Axumin, fluciclovine, PET, recurrence, scan, Treatment | Leave a comment »
Posted on September 11, 2017 by Sitemaster
In 2015, Inovio Pharmaceuticals started a Phase I trial of INO-5150 — a new type of immunotherapy using a DNA vaccine for prostate cancer which targets both prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: biochemical, DNA, INO-5150, recurrence, Treatment, vaccine | Leave a comment »
Posted on August 3, 2017 by Sitemaster
The gold standard for the clinical relevance of any new test in the management of a specific disease is … Do the results of the test change the way a physician would previously have managed patients? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gallium-68, Management, PET/CT, PSMA, recurrence, scan | 3 Comments »
Posted on June 29, 2017 by Sitemaster
A recent article (in German in Der Urologe) has discussed the early use of PSMA-radio-guided surgery (PSMA-RGS) for targeted resection of localized prostate cancer recurrence. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: identification, PSMA, radio-guidance, recurrence, surgery, tumor | 1 Comment »
Posted on June 21, 2017 by Sitemaster
Readers with a strong interest in the relationships between exercise and risk for cancer recurrence may want to download and read the full text of a recent article by Friedenreich et al. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: activity, exercise, physical, recurrence, risk | Leave a comment »
Posted on October 6, 2016 by Sitemaster
A newly published paper in the Journal of Urology provides additional data on the role of sophisticated, modern scanning methods in the management of men with recurrent prostate cancer after first-line surgical treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: C-11 choline, Mayo, recurrence, scan | 1 Comment »